Back to Journals » Vascular Health and Risk Management » Volume 9
Aldosterone receptor antagonists: current perspectives and therapies
Authors Guichard JL, Clark III D, Calhoun DA, Ahmed MI
Received 4 January 2013
Accepted for publication 5 March 2013
Published 24 June 2013 Volume 2013:9 Pages 321—331
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Jason L Guichard, Donald Clark III, David A Calhoun, Mustafa I Ahmed
University of Alabama at Birmingham, Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, Birmingham, AL, USA
Abstract: Aldosterone is a downstream effector of angiotensin II in the renin–angiotensin–aldosterone system and binds to the mineralocorticoid receptor. The classical view of aldosterone primarily acting at the level of the kidneys to regulate plasma potassium and intravascular volume status is being supplemented by evidence of new “off-target” effects of aldosterone in other organ systems. The genomic effects of aldosterone are well known, but there is also evidence for non-genomic effects and these recently identified effects of aldosterone have required a revision in the traditional view of aldosterone's role in human health and disease. The aim of this article is to review the biological action of aldosterone and the mineralocorticoid receptor leading to subsequent physiologic and pathophysiologic effects involving the vasculature, central nervous system, heart, and kidneys. Furthermore, we outline current evidence evaluating the use of mineralocorticoid receptor antagonists in the treatment of primary aldosteronism, primary hypertension, resistant hypertension, obstructive sleep apnea, heart failure, and chronic kidney disease.
Keywords: aldosterone antagonist, mineralocorticoid receptor antagonist, primary aldosteronism, hypertension, obstructive sleep apnea, heart failure, chronic kidney disease
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.